BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Inamura K. Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression. Int J Mol Sci 2018;19:E1259. [PMID: 29690599 DOI: 10.3390/ijms19041259] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Dong Y, Liu Y, Bai H, Jiao S. Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data. Sci Rep 2019;9:6301. [PMID: 31004093 DOI: 10.1038/s41598-019-42345-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
2 Wen Y, Lin A, Zhu W, Wei T, Luo P, Guo L, Zhang J. Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors. Front Pharmacol 2021;12:645862. [PMID: 34163353 DOI: 10.3389/fphar.2021.645862] [Reference Citation Analysis]
3 Tang W, Yu X, Zeng R, Chen L. LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells by Targeting the miR-200a/β-Catenin Pathway. Cancer Manag Res 2020;12:2001-14. [PMID: 32256108 DOI: 10.2147/CMAR.S240695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lu GS, Li M, Xu CX, Wang D. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma. Cell Death Dis 2018;9:1111. [PMID: 30382076 DOI: 10.1038/s41419-018-1162-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
5 Anichini A, Perotti VE, Sgambelluri F, Mortarini R. Immune Escape Mechanisms in Non Small Cell Lung Cancer. Cancers (Basel) 2020;12:E3605. [PMID: 33276569 DOI: 10.3390/cancers12123605] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
6 Hutchinson BD, Shroff GS, Truong MT, Ko JP. Spectrum of Lung Adenocarcinoma. Seminars in Ultrasound, CT and MRI 2019;40:255-64. [DOI: 10.1053/j.sult.2018.11.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
7 Zhao Z, He B, Cai Q, Zhang P, Peng X, Zhang Y, Xie H, Wang X. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma. Int Immunopharmacol 2021;98:107807. [PMID: 34175739 DOI: 10.1016/j.intimp.2021.107807] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Cheng T, Zhang Z, Cheng Y, Zhang J, Tang J, Tan Z, Liang Z, Chen T, Liu Z, Li J, Zhao J, Zhou R. ETV4 promotes proliferation and invasion of lung adenocarcinoma by transcriptionally upregulating MSI2. Biochemical and Biophysical Research Communications 2019;516:278-84. [DOI: 10.1016/j.bbrc.2019.06.115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
9 Wang Q, Ba W, Yin K, Shen J, Jiang G, Liang Y, Zhu Z, Wu J. Predicting lung adenocarcinoma invasiveness by measurement of pure ground-glass nodule roundness by using multiplanar reformation: a retrospective analysis. Clin Radiol 2021:S0009-9260(21)00484-0. [PMID: 34772486 DOI: 10.1016/j.crad.2021.10.007] [Reference Citation Analysis]
10 Beleaua MA, Jung I, Braicu C, Milutin D, Gurzu S. Relevance of BRAF Subcellular Localization and Its Interaction with KRAS and KIT Mutations in Skin Melanoma. Int J Mol Sci 2021;22:11918. [PMID: 34769348 DOI: 10.3390/ijms222111918] [Reference Citation Analysis]
11 Ahn S, Lim J, Park SY, Kim H, Kwon HJ, Han YB, Lee CT, Cho S, Chung JH. Genetic Alterations in Preinvasive Lung Synchronous Lesions. Cancer Res Treat 2020;52:1120-34. [PMID: 32599981 DOI: 10.4143/crt.2020.307] [Reference Citation Analysis]
12 Huang L, Jiang XL, Liang HB, Li JC, Chin LH, Wei JP, Wang RR, Cai J, Xiong Q, Wang LT, Cram DS, Liu AW. Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy options. Mol Med 2020;26:88. [PMID: 32942985 DOI: 10.1186/s10020-020-00197-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Ye J, Liu H, Xu ZL, Zheng L, Liu RY. Identification of a multidimensional transcriptome prognostic signature for lung adenocarcinoma. J Clin Lab Anal 2019;33:e22990. [PMID: 31402485 DOI: 10.1002/jcla.22990] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
14 Zhou Y, Höti N, Ao M, Zhang Z, Zhu H, Li L, Askin F, Gabrielson E, Zhang H, Li QK. Expression of p16 and p53 in non-small-cell lung cancer: clinicopathological correlation and potential prognostic impact. Biomark Med 2019;13:761-71. [PMID: 31157548 DOI: 10.2217/bmm-2018-0441] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
15 Chen T, Zhang X, Campisi A, Ciarrocchi AP, Dell'Amore A, Song L, Yang Y, Chen C, Luo Q. Evaluation of dynamic image progression of minimally invasive and preinvasive lung adenocarcinomas. Ann Transl Med 2021;9:804. [PMID: 34268417 DOI: 10.21037/atm-21-1994] [Reference Citation Analysis]
16 Zhou XJ, Li R, Liu X, Qu YQ. Advances in deubiquitinating enzymes in lung adenocarcinoma. J Cancer 2021;12:5573-82. [PMID: 34405018 DOI: 10.7150/jca.56532] [Reference Citation Analysis]
17 Wang Z, Li Z, Zhou K, Wang C, Jiang L, Zhang L, Yang Y, Luo W, Qiao W, Wang G, Ni Y, Dai S, Guo T, Ji G, Xu M, Liu Y, Su Z, Che G, Li W. Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencing. Nat Commun 2021;12:6500. [PMID: 34764257 DOI: 10.1038/s41467-021-26770-2] [Reference Citation Analysis]
18 Li J, Liu W, Dong X, Dai Y, Chen S, Zhao E, Liu Y, Bao H. The construction and analysis of ceRNA network and patterns of immune infiltration in lung adenocarcinoma. BMC Cancer 2021;21:1228. [PMID: 34781924 DOI: 10.1186/s12885-021-08932-z] [Reference Citation Analysis]
19 Hu HB, Yang XP, Zhou PX, Yang XA, Yin B. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma. Genes Genomics 2020;42:179-88. [PMID: 31768767 DOI: 10.1007/s13258-019-00889-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
20 Li Y, Li X, Li H, Zhao Y, Liu Z, Sun K, Zhu X, Qi Q, An B, Shen D, Li R, Liu T, Mi J, Wang L, Yang F, Bai F, Wang J. Genomic characterisation of pulmonary subsolid nodules: mutational landscape and radiological features. Eur Respir J 2020;55:1901409. [PMID: 31699841 DOI: 10.1183/13993003.01409-2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
21 Sen'kova AV, Savin IA, Brenner EV, Zenkova MA, Markov AV. Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study. PLoS One 2021;16:e0260450. [PMID: 34807957 DOI: 10.1371/journal.pone.0260450] [Reference Citation Analysis]
22 Li J, Liu X, Cui Z, Han G. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma. Med Sci Monit 2020;26:e922070. [PMID: 32578582 DOI: 10.12659/MSM.922070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Succony L, Rassl DM, Barker AP, McCaughan FM, Rintoul RC. Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies. Cancer Treat Rev 2021;99:102237. [PMID: 34182217 DOI: 10.1016/j.ctrv.2021.102237] [Reference Citation Analysis]
24 Pezzuto A, D'Ascanio M, Ricci A, Pagliuca A, Carico E. Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review. Thorac Cancer 2020;11:3060-70. [PMID: 32945604 DOI: 10.1111/1759-7714.13651] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
25 Zhang C, Zhang J, Xu FP, Wang YG, Xie Z, Su J, Dong S, Nie Q, Shao Y, Zhou Q, Yang JJ, Yang XN, Zhang XC, Li Z, Wu YL, Zhong WZ. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma. J Thorac Oncol 2019;14:1912-23. [PMID: 31446140 DOI: 10.1016/j.jtho.2019.07.031] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
26 Yang Q, Li J, Hu Y, Tang X, Yu L, Dong L, Chen D. MiR-218-5p Suppresses the Killing Effect of Natural Killer Cell to Lung Adenocarcinoma by Targeting SHMT1. Yonsei Med J 2019;60:500-8. [PMID: 31124332 DOI: 10.3349/ymj.2019.60.6.500] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
27 Jia M, Yu S, Cao L, Sun PL, Gao H. Clinicopathologic Features and Genetic Alterations in Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung: Long-Term Follow-Up Study of 121 Asian Patients. Ann Surg Oncol 2020;27:3052-63. [PMID: 32048092 DOI: 10.1245/s10434-020-08241-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Gan J, Li Y, Meng Q. Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-small-Cell Lung Cancer. Front Mol Biosci 2020;7:572406. [PMID: 33363204 DOI: 10.3389/fmolb.2020.572406] [Reference Citation Analysis]